DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Moore KN, Bookman M, Sehouli J. et al.
Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC).
Ann Oncol 2020;
31: S1161-S1162
DOI: 10.1016/j.annonc.2020.08.2261.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.